345 related articles for article (PubMed ID: 7834216)
1. Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
McDonald RL; Vaughan PF; Peers C
Br J Pharmacol; 1994 Oct; 113(2):621-7. PubMed ID: 7834216
[TBL] [Abstract][Full Text] [Related]
2. Role of L- and N-type Ca2+ channels in muscarinic receptor-mediated facilitation of ACh and noradrenaline release in the rat urinary bladder.
Somogyi GT; Zernova GV; Tanowitz M; de Groat WC
J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):645-54. PubMed ID: 9130161
[TBL] [Abstract][Full Text] [Related]
3. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
Murphy NP; McCormack JG; Ball SG; Vaughan PF
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
[TBL] [Abstract][Full Text] [Related]
4. Muscarine inhibits omega-conotoxin-sensitive calcium channels in a voltage- and time-dependent mode in the human neuroblastoma cell line SH-SY5Y.
Toselli M; Perin P; Taglietti V
J Neurophysiol; 1995 Oct; 74(4):1730-41. PubMed ID: 8989408
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors.
Reeve HL; Vaughan PF; Peers C
Neuropharmacology; 1995 Mar; 34(3):319-26. PubMed ID: 7630487
[TBL] [Abstract][Full Text] [Related]
6. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
Allen TG; Brown DA
J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor activation modulates Ca2+ channels in rat intracardiac neurons via a PTX- and voltage-sensitive pathway.
Jeong SW; Wurster RD
J Neurophysiol; 1997 Sep; 78(3):1476-90. PubMed ID: 9310437
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of depolarisation-evoked [(3)H]noradrenaline release from SH-SYFY human neuroblastoma cells by muscarinic (M1) receptors is not mediated by changes in [Ca(2+)].
Roberts DJ; Khan N; McDonald RL; Webster NJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2001 Feb; 87(1):81-91. PubMed ID: 11223162
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia.
Garnier M; Lamacz M; Galas L; Lenglet S; Tonon MC; Vaudry H
Endocrinology; 1998 Aug; 139(8):3525-33. PubMed ID: 9681504
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and omega-conotoxin.
Reeve HL; Vaughan PF; Peers C
Eur J Neurosci; 1994 Jun; 6(6):943-52. PubMed ID: 7952281
[TBL] [Abstract][Full Text] [Related]
11. Differential coupling of muscarinic receptors to Ca2+ mobilization and cyclic AMP in SH-SY5Y and IMR 32 neuroblastoma cells.
Heikkilä J; Jansson C; Akerman KE
Eur J Pharmacol; 1991 Sep; 208(1):9-15. PubMed ID: 1657623
[TBL] [Abstract][Full Text] [Related]
12. The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
Neurosci Lett; 1991 Aug; 129(2):229-32. PubMed ID: 1745405
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
15. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
Hill CE; Powis DA; Hendry IA
Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
[TBL] [Abstract][Full Text] [Related]
16. Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.
Waldmeier PC; Wicki P; Fröstl W; Bittiger H; Feldtrauer JJ; Baumann PA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):670-8. PubMed ID: 9053740
[TBL] [Abstract][Full Text] [Related]
17. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
Dobrev D; Milde AS; Andreas K; Ravens U
Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
[TBL] [Abstract][Full Text] [Related]
18. M4 muscarinic receptor activation modulates calcium channel currents in rat intracardiac neurons.
Cuevas J; Adams DJ
J Neurophysiol; 1997 Oct; 78(4):1903-12. PubMed ID: 9325359
[TBL] [Abstract][Full Text] [Related]
19. Etomidate inhibits [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells.
Sikand KS; Hirota K; Smith G; Lambert DG
Neurosci Lett; 1997 Oct; 236(2):87-90. PubMed ID: 9404818
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
McDonald RL; Kaye DF; Reeve HL; Ball SG; Peers C; Vaughan PF
Biochem Pharmacol; 1994 Jul; 48(1):23-30. PubMed ID: 8043027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
